跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 111,235 条关于
“advanced urothelial cancer”
全部
111,235
临床试验
86,686
药物
2,291
机构
1,239
资讯
21,019
去年
Flare Therapeutics Initiates Phase 1B Trial of First-in-Class PPARG Inhibitor FX-909 for Advanced Urothelial Cancer
去年
PADCEV-KEYTRUDA Combination Shows Sustained Survival Benefit in Advanced Urothelial Cancer Trial
6个月前
Flare Therapeutics Reports Promising Phase 1A Results for First-in-Class PPARG Inhibitor FX-909 in Advanced Urothelial Cancer
去年
Enfortumab Vedotin Plus Pembrolizumab Shows Promising 5-Year OS in Urothelial Cancer
去年
MD Anderson Reports Breakthrough in Metastatic Prostate Cancer Treatment with Targeted Therapy
11个月前
DISCUS Trial Shows 3 Cycles of Chemotherapy Improve Quality of Life Without Compromising Efficacy in Advanced Urothelial Cancer
去年
Phase 3 TROPiCS-04 Trial: Sacituzumab Govitecan Fails to Meet Survival Endpoints in Advanced Urothelial Cancer
去年
BL-B01D1, a Bispecific Antibody-Drug Conjugate, Shows Promise in Advanced Urothelial Cancer
去年
China NMPA Approves Padcev Plus Keytruda for Advanced Urothelial Cancer
2年前
China NMPA Accepts sBLA for Enfortumab Vedotin Plus Pembrolizumab in Advanced Bladder Cancer
第 1 页，共 2102 页
上一页
下一页
